Sergio Alfieri

Plain English
This study looked at how parents with cancer talk to their children about their illness and the challenges they face. Researchers interviewed ten parents and found that they deal with strong emotions and have many specific needs that often go unaddressed, such as the need for support and being able to continue their roles as parents. Understanding these challenges and needs is important for healthcare workers to provide better support to these families. Who this helps: This helps parents with cancer and their children.

Plain English
This study focused on salivary gland cancers (SGCs), which are rare and have few treatment options. Researchers analyzed 253 patients to see how different genetic markers could guide treatment decisions. They found that 47% of a specific type of SGC, adenoid cystic carcinoma (AdCC), had a certain genetic fusion, and high-aggression non-AdCCs showed harmful DNA changes in 55% of cases, with specific variants linked to treatment. This matters because a personalized testing approach could help doctors choose the best therapies for their patients. Who this helps: This helps patients with salivary gland cancers and their doctors by providing better testing and treatment options.

Plain English
This research focused on two clinical trials that looked at new treatments for patients with high-risk cutaneous squamous-cell carcinoma (cSCC) after surgery. The C-POST trial, which used a drug called cemiplimab, showed better disease-free survival (DFS) compared to the KEYNOTE-630 trial using pembrolizumab, achieving a combined risk reduction of recurrence by about 60% (HR 0.40). This is important because it suggests that certain patients with high-risk features may benefit significantly from these targeted therapies after surgery. Who this helps: This information helps patients with high-risk cSCC and their doctors in deciding on post-operative treatment options.

Plain English
This study explores a rare and serious condition called primary aortoenteric fistula (PADF), which can occur without the presence of an aortic aneurysm. The case involved a 71-year-old woman with ovarian cancer who experienced severe vomiting and abdominal pain; despite some initial tests not showing clear results, she was later diagnosed with PADF after suffering from recurrent gastrointestinal bleeding. Unfortunately, even after emergency surgery to repair the fistula, she developed multiple organ failure and passed away, highlighting the urgency for accurate diagnosis and timely treatment for these types of injuries. Who this helps: This information benefits doctors and healthcare professionals involved in treating patients with unexplained gastrointestinal bleeding, especially those with cancer.

Plain English
This study created a new toolkit called EUonQoL-Kit to help measure the quality of life of cancer patients and survivors in Europe. It was developed based on interviews and surveys with 230 participants from six countries and resulted in three questionnaires targeting patients in treatment, survivors, and those in palliative care, with each having between 44 and 75 questions. This matters because a better understanding of quality of life can improve cancer care and support health policy across Europe. Who this helps: This helps cancer patients, survivors, and doctors.

Plain English
This study looked at changes in proteins within pancreatic islets (clusters of cells that produce insulin) to find out how beta-cell dysfunction develops in people at risk for type 2 diabetes. Researchers found that individuals with impaired glucose tolerance had lower levels of several important proteins that help with energy use and insulin production. Specifically, those with lower sensitivity to glucose showed signs of reduced insulin processing and higher levels of proteins that could help in creating new beta cells, indicating that early problems in how the body handles glucose may lead to diabetes. Who this helps: This benefits patients at risk for type 2 diabetes and healthcare providers looking to identify early signs of the disease.

Plain English
This study examined a new method for managing blood pressure during major abdominal surgeries by using a measure called dynamic arterial elastance. Researchers found that while this method did not lower lactate levels (a marker of tissue oxygenation) after surgery, it led to patients needing less fluid and using more oxygen during recovery. This matters because it can help doctors refine how they treat blood pressure in surgery, potentially improving overall care without increasing the risk of complications. Who this helps: Patients undergoing major abdominal surgery.

Plain English
This study tested a new treatment plan for patients with advanced head and neck cancer, combining three methods: a drug called avelumab, low-dose chemotherapy, and targeted radiation. In a group of 20 patients, the treatment showed moderate results, with 5 people responding positively, but it didn't meet the goal of 6 responses to prove the treatment is effective. Overall, patients lived a median of 9.2 months after treatment, and some blood markers were linked to side effects and survival outcomes. Who this helps: This helps patients with recurrent or metastatic head and neck cancer.

Plain English
Researchers looked at how surgery compares to chemotherapy for patients with pancreatic cancer that has spread only to the liver. They analyzed data from 11 studies involving 897 patients and found that those who had surgery survived longer, with a median survival of about 10 to 18 months, compared to 6 to 9 months for those who received chemotherapy. This matter because it could change the way doctors treat pancreatic cancer patients with liver-only metastases to improve survival rates. Who this helps: Patients with pancreatic cancer that has spread to the liver.

Plain English
This study looked at how adding cetuximab to pembrolizumab can help patients with advanced skin cancer, specifically a type called cutaneous squamous cell carcinoma, that isn’t responding to treatment. They found that when cetuximab was added, 63% of patients showed some level of improvement compared to 44% who responded to pembrolizumab alone. This is important because it offers a new treatment option for patients who aren't benefiting from the initial therapy. Who this helps: This research helps patients with locally advanced or metastatic cutaneous squamous cell carcinoma facing treatment resistance.

Plain English
This study involved a team of 39 Italian experts who focused on improving how to manage a type of cancer called recurrent and/or metastatic head and neck squamous cell carcinoma (HNSCC). They agreed on 43 important points out of 45 about treatment practices, emphasizing the need for tests to determine the best treatment options and the importance of considering each patient's unique situation and overall health. This research is important because it aims to provide clearer guidelines for doctors, ensuring that patients receive more personalized and effective cancer care. Who this helps: Patients with head and neck squamous cell carcinoma and their healthcare providers.

Plain English
This study examined how different types of circular staplers used in colorectal surgeries affect the risk of anastomotic leakage, which is a serious complication. Researchers analyzed data from 21 studies involving over 24,500 patients and found that larger staplers (31/33 mm) had a higher leakage rate compared to smaller ones (28/29 mm), but there was no significant difference between the 25 mm and the 28/29 mm sizes. The study also showed that using powered staplers significantly reduced leakage rates compared to manual ones, and the single-stapling technique was better than the double-stapling technique in reducing leakage. Who this helps: This information benefits surgeons and patients undergoing colorectal surgery.

Plain English
This study looked at how to assess the difficulty of laparoscopic cholecystectomy surgery early on by analyzing video recordings of the procedure. The researchers developed a tool called SurgPrOD that uses deep learning to predict surgical difficulty, achieving improvements of at least 9% in accuracy compared to previous methods. Early detection of surgical challenges can lead to better planning and improved outcomes for patients. Who this helps: This helps patients undergoing laparoscopic cholecystectomy and the doctors performing the surgeries.

Plain English
This study looked at how well a new technology called ICG fluorescence angiography works when used with a robotic surgical system during a specific type of surgery for cecal cancer. The researchers found that this technology helped visualize blood flow in the intestines effectively, showing good blood supply to the surgical site, which is important for healing. This matters because ensuring proper blood flow can reduce complications and improve recovery for patients undergoing this type of surgery. Who this helps: Patients undergoing robotic surgery for cecal cancer.

Plain English
The study looked at a protein called BAG3 and its effect on how the pancreas releases insulin in people. Researchers found that patients with higher levels of BAG3 had trouble with the first phase of insulin secretion, leading to higher blood sugar levels after eating. Specifically, these patients had lower insulin responses during tests and higher glucose levels 30 and 60 minutes after a glucose challenge. Understanding how BAG3 works could help develop new ways to prevent the early stages of type 2 diabetes. Who this helps: This research benefits patients at risk of developing type 2 diabetes.

Plain English
This study looked at how two hormones, GIP and GLP-1, which help control blood sugar, are produced in people with different levels of glucose tolerance: normal, impaired, and diabetes. The researchers found that while the overall levels of both hormones were similar among the groups, the ratio of GIP to GLP-1 was lower in people with diabetes compared to those with normal or impaired glucose tolerance. This imbalance could indicate early signs of problems with insulin-producing cells in the pancreas, which is important for understanding diabetes progression. Who this helps: This helps patients at risk of developing type 2 diabetes and their doctors by identifying early warning signs of pancreatic dysfunction.

Plain English
This study looked at how well different methods measure the response of sinonasal cancer patients to induction chemotherapy. Researchers analyzed 60 patients and found that changes in the tumor volume were strongly linked to longer survival and a reduced risk of the cancer returning, with very significant p-values (less than 0.0001). In contrast, the standard RECIST criteria used for evaluation did not show a relationship with patient survival. Who this helps: This helps patients with sinonasal cancer and their doctors by providing better tools to assess treatment effectiveness.

Plain English
This study looked at 108 patients who had surgery for tumors in their mouth or throat between 1997 and 2022. The researchers found that 72% of patients had no cancer remaining after the surgery, but those with recurrent cancer had lower success rates, with only 64% achieving clear margins. Overall, 54% of patients were alive and cancer-free after an average of 51 months, highlighting that this surgical approach can be effective for advanced tumors when managed well. Who this helps: This benefits patients with advanced oral and oropharyngeal cancers seeking effective treatment options.

Plain English
This study examined techniques used by surgeons when connecting the ileum (part of the intestine) to the urethra during robotic surgeries for bladder reconstruction. With input from 21 experienced surgeons, the study found that 86% of participants viewed this connection step as challenging, with 25% of surgeries being difficult, and some surgeons reported needing to switch to a different procedure due to complications. Understanding these strategies is essential because they help make a complex surgery safer and more effective. Who this helps: This helps patients undergoing bladder reconstruction and the surgeons performing these operations.

Plain English
This study looked at patients with rare tumors called primary retroperitoneal sarcomas to see how postoperative complications and certain scoring systems affected their survival rates. Researchers found that 14.8% of patients experienced severe complications after surgery, but these complications did not affect overall survival or disease-free survival in the long term. Tools like the Sarculator and P-POSSUM scores can help doctors better assess risks for patients undergoing this type of surgery. Who this helps: This information benefits doctors and their patients facing surgery for primary retroperitoneal sarcomas.

Plain English
This study looked at how chronic pancreatitis affects hormone levels and diabetes, specifically focusing on hormones that regulate blood sugar. Researchers tested 32 patients with chronic pancreatitis and 60 without it, and found that diabetes was more common in those with chronic pancreatitis (56% compared to 33%). They discovered that problems with hormone secretion were linked to blood sugar control, but these issues were similar regardless of whether patients had chronic pancreatitis. Who this helps: This research benefits patients with chronic pancreatitis and diabetes, as well as doctors treating them.

Plain English
This study focused on how to assess the quality of life for cancer patients by identifying key areas that matter to them. Researchers gathered opinions from 96 cancer patients and 59 healthcare professionals across six European countries, ultimately agreeing that 20 specific areas, like pain and fear of recurrence, are crucial to measure during treatment and beyond. These findings are important because they will help create a new tool, the EUonQoL-Kit, to better evaluate and improve the quality of life for cancer patients. Who this helps: This helps cancer patients and their caregivers.

Plain English
This study looked at how different types of medical care affect women with advanced breast cancer. Researchers compared two groups of 80 patients: one received care from a single specialist, while the other had access to a team of specialists. The patients in the team-based care reported quicker follow-up appointments (1.7 weeks vs 2.8 weeks) and more information about support services, but felt less clear about their treatment options compared to those in the single specialist group. Who this helps: This helps patients with metastatic breast cancer by improving their access to support and information.

Plain English
This review looks at how cetuximab, a drug that targets a specific protein called EGFR, can be used to treat advanced non-melanoma skin cancers, especially in cases where other treatments haven't worked. The research highlights that cetuximab can be effective by itself or combined with other treatments like radiation, particularly for patients who cannot take immune checkpoint inhibitors due to resistance or other health issues. This matters because it provides alternative options for patients with difficult-to-treat skin cancers, potentially increasing their chances of a successful outcome. Who this helps: This helps patients with advanced non-melanoma skin cancer who have not responded to standard treatments.

Plain English
This study compared two chemotherapy regimens, De Gramont (DG) and XELOX/FOLFOX (OXA), to see which worked better for patients who had surgery for stomach cancer. Researchers looked at data from 255 patients and found that while both treatments had similar disease-free survival (DFS) of about 102.3 months for DG and 85.4 months for OXA, DG showed a trend towards better outcomes, with significantly improved overall survival (OS) of 119.5 months compared to 89.8 months for OXA. This matters because understanding which chemotherapy works best can help doctors make better treatment choices for patients, potentially leading to longer lives after surgery. Who this helps: This helps patients with stomach cancer and their doctors.

Plain English
This study looked at how levels of a virus linked to certain cancers (EBV) in the blood can predict outcomes for patients with nasopharyngeal cancer (NPC) who are not from high-risk areas. Researchers followed 167 patients, finding that most had detectable virus levels before treatment, but those who had no detectable virus afterwards lived longer without cancer returning—those with undetectable levels at follow-up had a recurrence prediction accuracy of 71% with a median lead time of 38 days. This research is important because it shows that monitoring EBV levels can significantly help doctors understand which patients might be at risk for their cancer coming back, improving early intervention strategies. Who this helps: This helps doctors and patients with non-endemic nasopharyngeal cancer manage treatment and follow-up care more effectively.

Plain English
This study focused on creating an Italian version of the FAMCARE-P13 questionnaire, which measures how satisfied cancer patients are with their healthcare. After testing it with 300 patients, the researchers found that the questionnaire is accurate and reliable, showing a high consistency score of 0.95 and strong stability over time. The results highlight that patients’ satisfaction is strongly linked to how available their doctors are for communication, which is important for improving care. Who this helps: This benefits patients with advanced cancer and their healthcare providers.

Plain English
This study looked at two types of heart conditions: intermittent ventricular pre-excitation (IPX) and persistent pre-excitation (PPX), focusing on their risks for sudden cardiac issues. Researchers analyzed data from 392 patients and found that while patients with IPX showed more frequent instances of a specific heart rhythm problem (AVRT), overall, there were no major differences in risk factors or symptoms between those with IPX and those with PPX. This means that relying on IPX as a sign of low risk for serious heart problems might not be accurate, suggesting the need for more detailed testing for patients with this condition. Who this helps: This information benefits doctors who treat patients with heart rhythm issues.

Plain English
This study looked at the effects of neo-adjuvant chemotherapy (NACT) on patients with stomach cancer who underwent surgery. It included 254 patients, comparing those who had NACT before surgery to those who had surgery right away. The study found that NACT did not lead to more complications or longer hospital stays, and five-year survival rates were similar between the two groups, with 44.6% for the NACT group and 47.7% for the surgery-first group. However, younger patients and those with fewer health issues tended to benefit more from NACT. Who this helps: This research benefits patients with gastric cancer and their doctors by helping them understand the safety of NACT before surgery.

Plain English
This study looked at how quickly levels of procalcitonin, a protein that indicates infection, rise and fall in patients who had surgery for appendicitis. Out of 33 patients, 4 developed abscesses after surgery, and their procalcitonin levels were consistently higher than those who didn't develop abscesses. This finding is important because it suggests that monitoring procalcitonin could help doctors identify patients at risk for complications sooner, leading to better treatment options. Who this helps: This helps patients recovering from appendicitis and their doctors by improving the ability to predict and address complications.

Plain English
The study looked into creating a Committee at a cancer institute in Milan made up of patients, caregivers, and patient association representatives. Researchers wanted to find out if staff agreed on key aspects of this Committee's role and functioning. Out of 90 experts surveyed, 8 of 13 statements received strong support, but when the topic was revisited, none of the points gained the necessary agreement to move forward, indicating that while there is interest in forming the Committee, more training and awareness are needed for successful implementation. Who this helps: This helps patients and caregivers by promoting their active involvement in cancer care and research.

Plain English
This study looked at the effects of systemic anticancer treatments in patients with advanced head and neck cancer who were nearing the end of their lives. It found that patients who received their last treatment within 30 days of death had a worse overall survival rate compared to those who finished treatment earlier, with one-third experiencing fatal side effects like respiratory failure and major bleeding. These results highlight the importance of carefully considering treatment options for patients close to the end of life and integrating palliative care sooner. Who this helps: This helps patients with advanced head and neck cancer and their doctors make more informed decisions about treatment options at the end of life.

Plain English
This study focused on how the cancer drug lenvatinib is used in real life for patients with advanced thyroid, salivary gland, endometrial, and liver cancers. Researchers looked at 161 patients over more than eight years and found that while lenvatinib is generally effective and manageable, many patients experienced fatigue, and those with a lower body weight often lost even more weight during treatment. This is important because it shows that lenvatinib can be effective, but doctors need to be cautious with patients who have lower body weights to avoid further health issues. Who this helps: Doctors and patients undergoing treatment for advanced cancers.

Plain English
This study examined how common exocrine pancreatic insufficiency (EPI) is in patients who have undergone gastric surgery and how it affects their quality of life. Out of 44 patients, 16 (36.4%) developed EPI, with 9 having moderate and 7 having severe EPI. Those with severe EPI had significantly lower quality of life scores (65) compared to those with no or moderate EPI (89), indicating that severe EPI leads to more gastrointestinal problems and lower overall well-being. Who this helps: This information is beneficial for patients who undergo gastric surgery, especially younger individuals and those with advanced cancer.

Plain English
This study looked at patients with advanced thyroid cancer who were assessed for specific genetic markers to determine their treatment options at a specialized medical center. Researchers found that 66.9% of the 133 patients had at least one actionable genetic target, and 43.6% received treatments that matched their genetic profiles. This is important because it shows that many patients could benefit from targeted therapies, making treatment more effective. Who this helps: Patients with advanced thyroid cancer.

Plain English
This study looked at two different surgical methods for treating cancer located in the neck of the pancreas, comparing extended pancreaticoduodenectomy and subtotal left pancreatectomy in 46 patients. It found that while both surgeries had similar overall survival rates, those who had subtotal left pancreatectomy lived longer without the disease returning, with an average of 16 months compared to 12 months for the other surgery. This matters because understanding which surgery offers better long-term outcomes can help guide treatment choices for patients with this type of cancer. Who this helps: This benefits patients with pancreatic neck cancer and their doctors by providing clearer options for surgical treatment.

Plain English
This study looked at how well patients with metastatic colorectal cancer (mCRC) do after having surgery to remove tumors, specifically focusing on those who had the surgery done more than once. Out of nearly 1,600 patients, 143 underwent at least two surgeries; they had a median time without cancer recurrence of 8.2 months after the second surgery and a 5-year survival rate of 73.1%. The research highlights that repeated surgeries can significantly improve survival for certain patients, and using a scoring system can help doctors choose who would benefit most from such procedures. Who this helps: This helps patients with metastatic colorectal cancer and their doctors.

Plain English
This study looked at using stem cells taken from fat tissue to treat stubborn intestinal leaks that can happen after abdominal surgery. Out of six patients, two-thirds (four patients) completely healed from their leaks within 4 to 12 weeks, and one more showed significant improvement. These results are important because they suggest a new, safe way to help patients who suffer from these difficult-to-treat conditions. Who this helps: Patients with complex postoperative enterocutaneous fistulas.

Plain English
This study looked at how effective combined chemotherapy and radiation (CRT) is for treating adenoid cystic carcinoma (ACC), a rare type of cancer that affects the salivary glands. Researchers analyzed data from 178 patients who received treatment between 2007 and 2022. They found that those who underwent CRT had a significantly longer time without distant metastasis than those treated with radiation alone, with an average of about 101 months compared to just under 40 months for selected patients. Who this helps: This research benefits patients with adenoid cystic carcinoma and their doctors by providing insight into treatment options that may delay cancer spread.

Plain English
This study looked at how frailty affects older patients (70 years and older) with a specific condition called acute left-sided colonic diverticulitis. Researchers found that patients who were severely frail had much higher rates of mortality (12 times higher) and sepsis compared to those who were less frail, and they also stayed in the hospital longer. This matters because understanding a patient’s frailty can help doctors provide better care and monitor those who are at greater risk for serious complications. Who this helps: This helps older patients and their doctors.

Plain English
This research paper focuses on Growth Differentiation Factor 15 (GDF15), a protein that can indicate how severe certain cancers are and also appears to affect their progression. The study found that higher levels of GDF15 are associated with worse outcomes in various cancers, such as head and neck, colorectal, and pancreatic cancers. Specifically, in head and neck cancers, high GDF15 levels link to more aggressive disease and lower chances of surviving treatments like chemotherapy and immunotherapy. Targeting GDF15 may improve treatment options, as shown by one study where a drug helped patients with weight loss linked to cancer. Who this helps: Patients with aggressive cancers and their doctors.

Plain English
The study focused on improving how doctors diagnose and classify tumors around the ampulla of Vater, an area where the bile duct and pancreas meet. A team of 43 experts reviewed over 37,000 research articles and came up with 51 recommendations. They aimed to reduce confusion and ensure accurate patient care by providing clearer definitions and guidelines for these tumors. This is important because it will lead to better diagnosis and treatment options for patients with these specific types of cancers. Who this helps: Patients with ampullary tumors and their healthcare teams.